CordenPharma Small Molecules Platform

Full-service Partner of Choice from
Advanced Intermediates to Drug Products

Platform Manager
Dr. Stephen Houldsworth
Director, Global Small Molecules & Antibiotics Platforms, 
CordenPharma International
  • Diversified and multi-purpose services with extensive capabilities from small scale to large scale, spanning development to commercial manufacturing.
  • Multiple manufacturing locations across Europe and USA offering flexibility of supply.
  • Full-service offering and project management from Advanced Intermediates and APIs to final Drug Products including packaging/labeling and clinical trial drug kits management (logistics, track-trace & documentation).

Platform Description

CordenPharma’s Small Molecule Platform provides full-service capabilities from Advanced Intermediates and API Development & Manufacturing to Drug Products (Formulation & Packaging). Our network of facilities utilize multi-purpose equipment from development to commercial supply servicing innovators and generic companies.

Small Molecule APIs and Excipients are manufactured in CordenPharma Chenôve (FR), CordenPharma Colorado (USA), CordenPharma Bergamo (IT), and CordenPharma Switzerland (CH). Small Molecule Drug Products are manufactured in CordenPharma Plankstadt (DE) and CordenPharma Caponago (IT). 

Platform Capabilities

Small Molecules
  • Small Molecule APIs & Excipients
    • Proprietary Advanced Intermediates & APIs
    • Generic Advanced Intermediates & APIs
  • Small Molecule Drug Products
    • Solid Oral Drug Product
    • Terminally Sterilized Injectable Drug Products (Barrel Syringes, Vials & Ampoules)
    • Aseptic Filled Injectable Drug Products (Cartridges, Vials & PFS)
    • Packaging & Labeling
    • Sterile Emulsion Technology
    • Clinical Trial Services
      • Kit Preparation & Shipping
      • Management of Unused Medications
      • Fully Documented Track & Trace System

Facilities Included in Platform